VRDNViridian Therapeutics, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $18.84 (+0.00% today)

Market Cap: $1.60B

P/E (TTM): -4.70

Analyst Upside: 144.2%

Relative Strength (RS%): 1

-45.1% from 52-week high

Back to Scanner

VRDN

NASDAQRS 1Score 15

Viridian Therapeutics, Inc.

HealthcareBiotechnology$1.60B1 setup passing
$18.84
0.0% ($0.00)
-45.1% from 52W High
P/E (TTM)
-4.70
Fwd P/E
PEG
Analyst Upside
+144.2%
EPS Growth
Gross Margin
99.5%
ROE
-58.4%
D/E
0.07
Div Yield
0.0%
Avg Volume
3.1M

Price Chart

Key Levels

SMA 200
$24.44
SMA 50
$28.99
Price
$18.84
52W High
$34.32
Target
$46.00

Setup Radar

1/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst